AutoGenomics, Inc. · Carlsbad, CA United States ·(NASDAQ (GM): AGMX)
Company Description
View AutoGenomics, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window AutoGenomics is mapping the road to the future of medicine. The company developed a genetic testing system called INFINITI that scans DNA samples for genetic disorders, infectious diseases, cancer, and pharmacogenetics (a patient's genetic likeliness to have an adverse reaction to a drug). AutoGenomics found about 25 uses for the INFINITI, but only four have been approved by the FDA for diagnostic use -- testing for sensitivity to the popular blood thinner warfarin, screening for the risk of developing cystic fibrosis or cervical cancer (for women with HPV), and testing for a gene that blocks common drugs from working. AutoGenomics was founded in 1999 as Neuron Technologies and applied to go public in 2008.
To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key AutoGenomics, Inc. Financials
| Company Type | Private - NASDAQ (GM): AGMX Single Location |
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1.6 |
| 2007 Employees | 103 |
AutoGenomics, Inc. Executives
16 executives listed for AutoGenomics, Inc.'s Carlsbad, CA location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Fareed Kureshy | Network |
| COO, CFO, Secretary, and Director | Thomas Hennessey | Network |
| Chief Scientific Officer | Nanibhushan Dattagupta | Network |
Competition
Top AutoGenomics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!